focal spasticity
Neurology · 2005–2006
3decisions
1medicine
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| Botulinum Toxin Type A Purified Neurotoxin Complex Treatment of focal spasticity in adults when there is no fixed muscle contracture to limit treatment efficacy, non-invasive treatments (physical therapies)… | Jul 2006 | Not recommended | no section in document |
| botulinum toxin type A purified neurotoxin complex treatment of focal spasticity in adults | Nov 2005 | Not recommended | no section in document |
| botulinum toxin type A purified neurotoxin complex Treatment of focal spasticity in adults. | Nov 2005 | Not recommended | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.